The MHC Class-I Transactivator NLRC5: Implications to Cancer Immunology and Potential Applications to Cancer Immunotherapy

The immune system constantly monitors the emergence of cancerous cells and eliminates them. CD8(+) cytotoxic T lymphocytes (CTLs), which kill tumor cells and provide antitumor immunity, select their targets by recognizing tumor antigenic peptides presented by MHC class-I (MHC-I) molecules. Cancer ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Shukla, Akhil, Cloutier, Maryse, Appiya Santharam, Madanraj, Ramanathan, Sheela, Ilangumaran, Subburaj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922096/
https://www.ncbi.nlm.nih.gov/pubmed/33671123
http://dx.doi.org/10.3390/ijms22041964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922096/
https://www.ncbi.nlm.nih.gov/pubmed/33671123
http://dx.doi.org/10.3390/ijms22041964

Ejemplares similares